Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2018-04-18

Clinical Trial Update: Leptospermum Scoparium Honey and Wound Care for Pressure Ulcers [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating Leptospermum scoparium honey-based wound care for pressure ulcers has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leptospermum scoparium honey wound care (Leptospermum scoparium honey)

Snippet

Sponsor: New York City Health and Hospitals Corporation | Conditions: Pressure Ulcers | Phase 4 | Status: WITHDRAWN